NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

RECRUITING

Research Site, Berlin

RECRUITING

Research Site, Bottrop

RECRUITING

Research Site, Brandenburg

RECRUITING

Research Site, Dessau

RECRUITING

Research Site, Ebersberg

RECRUITING

Research Site, Gütersloh

RECRUITING

Research Site, Landshut

RECRUITING

Research Site, Lüneburg

RECRUITING

Research Site, Mainz

RECRUITING

Research Site, Plauen

RECRUITING

Research Site, Unna

RECRUITING

Research Site, Worms